Generic placeholder image

Nanoscience & Nanotechnology-Asia

Editor-in-Chief

ISSN (Print): 2210-6812
ISSN (Online): 2210-6820

Mini-Review Article

Overactive Bladder (OAB) Management: An Overview and Scope of Nano Drug Carriers

Author(s): Vikash Kumar* and Sandeep Rathor

Volume 11, Issue 6, 2021

Published on: 08 January, 2021

Article ID: e080121190007 Pages: 9

DOI: 10.2174/2210681210666210108111413

Price: $65

Abstract

All groups/patient's quality of life (QOL) is affected because of overactive bladder (OAB), which leads to symptoms like urgency/urinary frequency/incontinence and nocturia. Several patients do not undergo management because of the embarrassment/misconception i.e. it is related to aging only and even discontinue the treatment due to side effects (repeated incidences). The objective of this review is to explore all management methods (including active ingredients involved in the treatment) and envisage the future scope of the different nano methods with minimizing apparent side effects to achieve a significant effect.

Keywords: OAB, QOL, management, methods, side effects, overactive bladder.

Graphical Abstract

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy